115 related articles for article (PubMed ID: 8396402)
1. Antibodies in human sera recognizing a recombinant outer membrane protein encoded by the envelope gene of the human endogenous retrovirus K.
Vogetseder W; Dumfahrt A; Mayersbach P; Schönitzer D; Dierich MP
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):687-94. PubMed ID: 8396402
[TBL] [Abstract][Full Text] [Related]
2. Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.
Tönjes RR; Limbach C; Löwer R; Kurth R
J Virol; 1997 Apr; 71(4):2747-56. PubMed ID: 9060628
[TBL] [Abstract][Full Text] [Related]
3. Detection of a 67-kD glycoprotein in human tumor cell lines by a monoclonal antibody established against a recombinant human endogenous retrovirus-K envelope-gene-encoded protein.
Vogetseder W; Feng J; Haibach C; Mayerl W; Dierich MP
Exp Clin Immunogenet; 1995; 12(2):96-102. PubMed ID: 7576722
[TBL] [Abstract][Full Text] [Related]
4. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.
Wang-Johanning F; Frost AR; Johanning GL; Khazaeli MB; LoBuglio AF; Shaw DR; Strong TV
Clin Cancer Res; 2001 Jun; 7(6):1553-60. PubMed ID: 11410490
[TBL] [Abstract][Full Text] [Related]
5. HERV-K: the biologically most active human endogenous retrovirus family.
Tönjes RR; Löwer R; Boller K; Denner J; Hasenmaier B; Kirsch H; König H; Korbmacher C; Limbach C; Lugert R; Phelps RC; Scherer J; Thelen K; Löwer J; Kurth R
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S261-7. PubMed ID: 8797733
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
7. Localization of immunogenic domains in the human immunodeficiency virus type 2 envelope.
Huang ML; Essex M; Lee TH
J Virol; 1991 Sep; 65(9):5073-9. PubMed ID: 1714524
[TBL] [Abstract][Full Text] [Related]
8. Increased immunoglobulin G, but not M, binding to endogenous retroviral antigens in HIV-1 infected persons.
Lawoko A; Johansson B; Rabinayaran D; Pipkorn R; Blomberg J
J Med Virol; 2000 Dec; 62(4):435-44. PubMed ID: 11074471
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
Wang-Johanning F; Rycaj K; Plummer JB; Li M; Yin B; Frerich K; Garza JG; Shen J; Lin K; Yan P; Glynn SA; Dorsey TH; Hunt KK; Ambs S; Johanning GL
J Natl Cancer Inst; 2012 Feb; 104(3):189-210. PubMed ID: 22247020
[TBL] [Abstract][Full Text] [Related]
10. Molecular biology of type A endogenous retrovirus.
Ono M
Kitasato Arch Exp Med; 1990 Sep; 63(2-3):77-90. PubMed ID: 1710682
[TBL] [Abstract][Full Text] [Related]
11. Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.
Cham F; Zhang PF; Heyndrickx L; Bouma P; Zhong P; Katinger H; Robinson J; van der Groen G; Quinnan GV
Virology; 2006 Mar; 347(1):36-51. PubMed ID: 16378633
[TBL] [Abstract][Full Text] [Related]
12. Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infection.
Shafferman A; Lennox J; Grosfeld H; Sadoff J; Redfield RR; Burke DS
AIDS Res Hum Retroviruses; 1989 Feb; 5(1):33-9. PubMed ID: 2541748
[TBL] [Abstract][Full Text] [Related]
13. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.
Wang-Johanning F; Liu J; Rycaj K; Huang M; Tsai K; Rosen DG; Chen DT; Lu DW; Barnhart KF; Johanning GL
Int J Cancer; 2007 Jan; 120(1):81-90. PubMed ID: 17013901
[TBL] [Abstract][Full Text] [Related]
14. [Gene products of human endogenous retrovirus (HERV)-K in germ cell and trophoblastic tumors].
Herbst H; Sauter M; Fuchs H; Kühler-Obbarius C; Löning T; Mueller-Lantzsch N
Verh Dtsch Ges Pathol; 1997; 81():464-70. PubMed ID: 9474889
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDS.
Goedert JJ; Sauter ME; Jacobson LP; Vessella RL; Hilgartner MW; Leitman SF; Fraser MC; Mueller-Lantzsch NG
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):293-6. PubMed ID: 10207631
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human endogenous retrovirus type K virus-like particles generated from recombinant baculoviruses.
Tönjes RR; Boller K; Limbach C; Lugert R; Kurth R
Virology; 1997 Jul; 233(2):280-91. PubMed ID: 9217052
[TBL] [Abstract][Full Text] [Related]
17. Alveolar macrophages produce the Env protein of a human endogenous retrovirus, HERV-E 4-1, in a subgroup of interstitial lung diseases.
Tamura N; Iwase A; Suzuki K; Maruyama N; Kira S
Am J Respir Cell Mol Biol; 1997 Apr; 16(4):429-37. PubMed ID: 9115754
[TBL] [Abstract][Full Text] [Related]
18. Human antibodies to HIV-1 by recombinant DNA methods.
Burton DR; Barbas CF
Chem Immunol; 1993; 56():112-26. PubMed ID: 8452652
[No Abstract] [Full Text] [Related]
19. Two groups of endogenous MMTV related retroviral env transcripts expressed in human tissues.
Willer A; Saussele S; Gimbel W; Seifarth W; Kister P; Leib-Mösch C; Hehlmann R
Virus Genes; 1997; 15(2):123-33. PubMed ID: 9421877
[TBL] [Abstract][Full Text] [Related]
20. Insertion of a short human immunodeficiency virus (HIV)-2 gp36 sequence into an HIV-1 p24 recombinant protein results in a polypeptide with potent and TCRBV-restricted T cell triggering activity.
Imberti L; Sottini A; Quiròs Roldan E; Albertini A; Mattioli S; Prati E; Primi D
Eur J Immunol; 1995 Jan; 25(1):218-25. PubMed ID: 7843234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
